Clinical Trial Detail

NCT ID NCT02491411
Title Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Dexamethasone

Age Groups: adult

No variant requirements are available.